SFENCC2020 Society for Endocrinology National Clinical Cases 2020 Poster Presentations (72 abstracts)
Breast Cancer in MEN1: Coincidence or association?
Seong Keat Cheah 1 , Bisambar Chad 1 , Deborah Pitfield 1 , Olivier Giger 1 , Rogier ten Hoopen 1 , Jose Ezequiel Martin 1 , Soo-Mi Park 1 , Craig Parkinson 2 , Benjamin Challis 1 & Ruth Casey 1
1Cambridge University Hospital Foundation Trust, Cambridge, UK; 2East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK
Section 1: Case history: A 38 year old female was identified as carrying a heterozygous pathogenic MEN1 variant (c.13404delG) through predictive testing, following a diagnosis of familial hyperparathyroidism.
Section 2: Investigations: Routine screening for hyperparathyroidism and pituitary disease was negative. However, a CT thorax–abdomen–pelvis revealed a 41 mm pancreatic tail mass. Biopsy via endoscopic ultrasound confirmed a well-differentiated (grade 1) pancreatic neuroendocrine tumour (pNET) with MIB1<1%. Biochemically, hyperinsulinaemic hypoglycaemia was confirmed following an overnight fast, and subsequently managed by diet prior to definitive surgery. Pre-operative work up with Octreotide scan demonstrated avid tracer uptake in the pancreatic lesion as well as a focal area of uptake in the left breast.
Section 3: Results and treatment: Further investigation and subsequent mastectomy confirmed ductal carcinoma in situ pT2 (23 mm) grade 1, N0 (ER positive; HER2 negative). Following this, she underwent a successful pancreatectomy and splenectomy. Patchy insulin staining was seen on the pNET with no lymph node spread.
Section 4: Conclusions and points for discussion: MEN1’s association with breast cancer is unclear. Previously, 12 cases of breast cancer were reported in a cohort of 190 MEN1 females (Dreijerink et al. 2014). This cohort had early-onset breast cancer diagnosed at a young median age of 48 years, in line with our patient’s history. In our patient, loss of heterozygosity (LOH) at the MEN1 locus was seen in the breast tissue and pNET specimen, in keeping with a ‘two-hit’ hypothesis of oncogenesis, a suggestive but non-definitive clue for causation. However, only 3/9 cases showed loss of heterozygosity (LOH) in the Dutch cohort. Of note, somatic truncating BRCA2 and TP53 mutations were also identified in the breast tumour but the variant allele frequency of < 10% for both mutations suggesting that these mutations were sub-clonal rather than the primary genetic driver. This case highlights the need for further studies to determine the potential role of MEN1 in breast cancer development and to guide surveillance strategies.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more